Loading…
TREM2 deficiency inhibits microglial activation and aggravates demyelinating injury in neuromyelitis optica spectrum disorder
Neuromyelitis optica spectrum disorder (NMOSD) is an inflammatory demyelinating disorder of the central nervous system (CNS) triggered by autoimmune mechanisms. Microglia are activated and play a pivotal role in response to tissue injury. Triggering receptor expressed on myeloid cells 2 (TREM2) is e...
Saved in:
Published in: | Journal of neuroinflammation 2023-04, Vol.20 (1), p.89-89, Article 89 |
---|---|
Main Authors: | , , , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c564t-fd84918ccbb2db396f3394d2a044814e71eff796e16eeeabd5548371a3be21e53 |
---|---|
cites | cdi_FETCH-LOGICAL-c564t-fd84918ccbb2db396f3394d2a044814e71eff796e16eeeabd5548371a3be21e53 |
container_end_page | 89 |
container_issue | 1 |
container_start_page | 89 |
container_title | Journal of neuroinflammation |
container_volume | 20 |
creator | You, Yun-Fan Chen, Man Tang, Yue Yu, Wen-Xiang Pang, Xiao-Wei Chu, Yun-Hui Zhang, Hang Shang, Ke Deng, Gang Zhou, Luo-Qi Yang, Sheng Wang, Wei Xiao, Jun Tian, Dai-Shi Qin, Chuan |
description | Neuromyelitis optica spectrum disorder (NMOSD) is an inflammatory demyelinating disorder of the central nervous system (CNS) triggered by autoimmune mechanisms. Microglia are activated and play a pivotal role in response to tissue injury. Triggering receptor expressed on myeloid cells 2 (TREM2) is expressed by microglia and promotes microglial activation, survival and phagocytosis. Here, we identify a critical role for TREM2 in microglial activation and function during AQP4-IgG and complement-induced demyelination. TREM2-deficient mice had more severe tissue damage and neurological impairment, as well as fewer oligodendrocytes with suppressed proliferation and maturation. The number of microglia clustering in NMOSD lesions and their proliferation were reduced in TREM2-deficient mice. Moreover, morphology analysis and expression of classic markers showed compromised activation of microglia in TREM2-deficient mice, which was accompanied by suppressed phagocytosis and degradation of myelin debris by microglia. These results overall indicate that TREM2 is a key regulator of microglial activation and exert neuroprotective effects in NMOSD demyelination. |
doi_str_mv | 10.1186/s12974-023-02772-3 |
format | article |
fullrecord | <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_640bed233aa54a44b7d224c0af3bb0b4</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A744216933</galeid><doaj_id>oai_doaj_org_article_640bed233aa54a44b7d224c0af3bb0b4</doaj_id><sourcerecordid>A744216933</sourcerecordid><originalsourceid>FETCH-LOGICAL-c564t-fd84918ccbb2db396f3394d2a044814e71eff796e16eeeabd5548371a3be21e53</originalsourceid><addsrcrecordid>eNptUk1v1DAQjRCIloU_wAFF4sIlxV-JkxOqqgKVipBQOVtje5J6ldiLnVTaQ_873t1Sughblu2Zec8z41cUbyk5o7RtPibKOikqwnheUrKKPytOqRSsYqQTz5-cT4pXKa0J4axu2MvihEtCeS34aXF_8-PyGyst9s449GZbOn_rtJtTOTkTwzA6GEsws7uD2QVfgrclDEOEfMeUgdMWR-ez0w8Zu17ijqL0uMSwd80ulWEzOwNl2qCZ4zKV1qUQLcbXxYsexoRvHvZV8fPz5c3F1-r6-5eri_PrytSNmKvetqKjrTFaM6t51_Scd8IyIEK0VKCk2Peya5A2iAja1rVouaTANTKKNV8VVwdeG2CtNtFNELcqgFN7Q4iDgphTHFE1gmi0jHOAWoAQWlrGhCHQc62JFpnr04Frs-gJrUE_RxiPSI893t2qIdwpSkjTEbnL5sMDQwy_FkyzmlwyOI7gMSxJMdnVvKE8j1Xx_p_QdViiz71SrCWcCMkb8TdqgFyB833ID5sdqTqXQjDadHuus_9E5Zn_0JngswSy_QjADoCsg5Qi9o9FUqJ2ClQHBaqsQLVXoNqB3j1tzyPkj-T4b9ii2IU</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2803047364</pqid></control><display><type>article</type><title>TREM2 deficiency inhibits microglial activation and aggravates demyelinating injury in neuromyelitis optica spectrum disorder</title><source>PubMed Central Free</source><source>Publicly Available Content Database</source><creator>You, Yun-Fan ; Chen, Man ; Tang, Yue ; Yu, Wen-Xiang ; Pang, Xiao-Wei ; Chu, Yun-Hui ; Zhang, Hang ; Shang, Ke ; Deng, Gang ; Zhou, Luo-Qi ; Yang, Sheng ; Wang, Wei ; Xiao, Jun ; Tian, Dai-Shi ; Qin, Chuan</creator><creatorcontrib>You, Yun-Fan ; Chen, Man ; Tang, Yue ; Yu, Wen-Xiang ; Pang, Xiao-Wei ; Chu, Yun-Hui ; Zhang, Hang ; Shang, Ke ; Deng, Gang ; Zhou, Luo-Qi ; Yang, Sheng ; Wang, Wei ; Xiao, Jun ; Tian, Dai-Shi ; Qin, Chuan</creatorcontrib><description>Neuromyelitis optica spectrum disorder (NMOSD) is an inflammatory demyelinating disorder of the central nervous system (CNS) triggered by autoimmune mechanisms. Microglia are activated and play a pivotal role in response to tissue injury. Triggering receptor expressed on myeloid cells 2 (TREM2) is expressed by microglia and promotes microglial activation, survival and phagocytosis. Here, we identify a critical role for TREM2 in microglial activation and function during AQP4-IgG and complement-induced demyelination. TREM2-deficient mice had more severe tissue damage and neurological impairment, as well as fewer oligodendrocytes with suppressed proliferation and maturation. The number of microglia clustering in NMOSD lesions and their proliferation were reduced in TREM2-deficient mice. Moreover, morphology analysis and expression of classic markers showed compromised activation of microglia in TREM2-deficient mice, which was accompanied by suppressed phagocytosis and degradation of myelin debris by microglia. These results overall indicate that TREM2 is a key regulator of microglial activation and exert neuroprotective effects in NMOSD demyelination.</description><identifier>ISSN: 1742-2094</identifier><identifier>EISSN: 1742-2094</identifier><identifier>DOI: 10.1186/s12974-023-02772-3</identifier><identifier>PMID: 37013543</identifier><language>eng</language><publisher>England: BioMed Central Ltd</publisher><subject>Alcohol ; Alzheimer's disease ; Animals ; Antibodies ; Aquaporin 4 ; Brain ; Care and treatment ; Central Nervous System ; Complement activation ; Cytotoxicity ; Demyelinating diseases ; Demyelination ; Diagnosis ; Dosage and administration ; Immunoglobulin G ; Membrane Glycoproteins - genetics ; Membrane Glycoproteins - metabolism ; Mice ; Microglia ; Microglia - metabolism ; Microscopy ; Morphology ; Myelin ; Myelin Sheath - metabolism ; Myeloid cells ; Neurological complications ; Neuromyelitis ; Neuromyelitis optica ; Neuromyelitis Optica - metabolism ; Neuromyelitis optica spectrum disorder ; Neuroprotection ; Oligodendrocytes ; Phagocytosis ; Phagocytosis - genetics ; Proteins ; Receptors, Immunologic - genetics ; Receptors, Immunologic - metabolism ; TREM2</subject><ispartof>Journal of neuroinflammation, 2023-04, Vol.20 (1), p.89-89, Article 89</ispartof><rights>2023. The Author(s).</rights><rights>COPYRIGHT 2023 BioMed Central Ltd.</rights><rights>2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>The Author(s) 2023</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c564t-fd84918ccbb2db396f3394d2a044814e71eff796e16eeeabd5548371a3be21e53</citedby><cites>FETCH-LOGICAL-c564t-fd84918ccbb2db396f3394d2a044814e71eff796e16eeeabd5548371a3be21e53</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10069075/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2803047364?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37013543$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>You, Yun-Fan</creatorcontrib><creatorcontrib>Chen, Man</creatorcontrib><creatorcontrib>Tang, Yue</creatorcontrib><creatorcontrib>Yu, Wen-Xiang</creatorcontrib><creatorcontrib>Pang, Xiao-Wei</creatorcontrib><creatorcontrib>Chu, Yun-Hui</creatorcontrib><creatorcontrib>Zhang, Hang</creatorcontrib><creatorcontrib>Shang, Ke</creatorcontrib><creatorcontrib>Deng, Gang</creatorcontrib><creatorcontrib>Zhou, Luo-Qi</creatorcontrib><creatorcontrib>Yang, Sheng</creatorcontrib><creatorcontrib>Wang, Wei</creatorcontrib><creatorcontrib>Xiao, Jun</creatorcontrib><creatorcontrib>Tian, Dai-Shi</creatorcontrib><creatorcontrib>Qin, Chuan</creatorcontrib><title>TREM2 deficiency inhibits microglial activation and aggravates demyelinating injury in neuromyelitis optica spectrum disorder</title><title>Journal of neuroinflammation</title><addtitle>J Neuroinflammation</addtitle><description>Neuromyelitis optica spectrum disorder (NMOSD) is an inflammatory demyelinating disorder of the central nervous system (CNS) triggered by autoimmune mechanisms. Microglia are activated and play a pivotal role in response to tissue injury. Triggering receptor expressed on myeloid cells 2 (TREM2) is expressed by microglia and promotes microglial activation, survival and phagocytosis. Here, we identify a critical role for TREM2 in microglial activation and function during AQP4-IgG and complement-induced demyelination. TREM2-deficient mice had more severe tissue damage and neurological impairment, as well as fewer oligodendrocytes with suppressed proliferation and maturation. The number of microglia clustering in NMOSD lesions and their proliferation were reduced in TREM2-deficient mice. Moreover, morphology analysis and expression of classic markers showed compromised activation of microglia in TREM2-deficient mice, which was accompanied by suppressed phagocytosis and degradation of myelin debris by microglia. These results overall indicate that TREM2 is a key regulator of microglial activation and exert neuroprotective effects in NMOSD demyelination.</description><subject>Alcohol</subject><subject>Alzheimer's disease</subject><subject>Animals</subject><subject>Antibodies</subject><subject>Aquaporin 4</subject><subject>Brain</subject><subject>Care and treatment</subject><subject>Central Nervous System</subject><subject>Complement activation</subject><subject>Cytotoxicity</subject><subject>Demyelinating diseases</subject><subject>Demyelination</subject><subject>Diagnosis</subject><subject>Dosage and administration</subject><subject>Immunoglobulin G</subject><subject>Membrane Glycoproteins - genetics</subject><subject>Membrane Glycoproteins - metabolism</subject><subject>Mice</subject><subject>Microglia</subject><subject>Microglia - metabolism</subject><subject>Microscopy</subject><subject>Morphology</subject><subject>Myelin</subject><subject>Myelin Sheath - metabolism</subject><subject>Myeloid cells</subject><subject>Neurological complications</subject><subject>Neuromyelitis</subject><subject>Neuromyelitis optica</subject><subject>Neuromyelitis Optica - metabolism</subject><subject>Neuromyelitis optica spectrum disorder</subject><subject>Neuroprotection</subject><subject>Oligodendrocytes</subject><subject>Phagocytosis</subject><subject>Phagocytosis - genetics</subject><subject>Proteins</subject><subject>Receptors, Immunologic - genetics</subject><subject>Receptors, Immunologic - metabolism</subject><subject>TREM2</subject><issn>1742-2094</issn><issn>1742-2094</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNptUk1v1DAQjRCIloU_wAFF4sIlxV-JkxOqqgKVipBQOVtje5J6ldiLnVTaQ_873t1Sughblu2Zec8z41cUbyk5o7RtPibKOikqwnheUrKKPytOqRSsYqQTz5-cT4pXKa0J4axu2MvihEtCeS34aXF_8-PyGyst9s449GZbOn_rtJtTOTkTwzA6GEsws7uD2QVfgrclDEOEfMeUgdMWR-ez0w8Zu17ijqL0uMSwd80ulWEzOwNl2qCZ4zKV1qUQLcbXxYsexoRvHvZV8fPz5c3F1-r6-5eri_PrytSNmKvetqKjrTFaM6t51_Scd8IyIEK0VKCk2Peya5A2iAja1rVouaTANTKKNV8VVwdeG2CtNtFNELcqgFN7Q4iDgphTHFE1gmi0jHOAWoAQWlrGhCHQc62JFpnr04Frs-gJrUE_RxiPSI893t2qIdwpSkjTEbnL5sMDQwy_FkyzmlwyOI7gMSxJMdnVvKE8j1Xx_p_QdViiz71SrCWcCMkb8TdqgFyB833ID5sdqTqXQjDadHuus_9E5Zn_0JngswSy_QjADoCsg5Qi9o9FUqJ2ClQHBaqsQLVXoNqB3j1tzyPkj-T4b9ii2IU</recordid><startdate>20230403</startdate><enddate>20230403</enddate><creator>You, Yun-Fan</creator><creator>Chen, Man</creator><creator>Tang, Yue</creator><creator>Yu, Wen-Xiang</creator><creator>Pang, Xiao-Wei</creator><creator>Chu, Yun-Hui</creator><creator>Zhang, Hang</creator><creator>Shang, Ke</creator><creator>Deng, Gang</creator><creator>Zhou, Luo-Qi</creator><creator>Yang, Sheng</creator><creator>Wang, Wei</creator><creator>Xiao, Jun</creator><creator>Tian, Dai-Shi</creator><creator>Qin, Chuan</creator><general>BioMed Central Ltd</general><general>BioMed Central</general><general>BMC</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20230403</creationdate><title>TREM2 deficiency inhibits microglial activation and aggravates demyelinating injury in neuromyelitis optica spectrum disorder</title><author>You, Yun-Fan ; Chen, Man ; Tang, Yue ; Yu, Wen-Xiang ; Pang, Xiao-Wei ; Chu, Yun-Hui ; Zhang, Hang ; Shang, Ke ; Deng, Gang ; Zhou, Luo-Qi ; Yang, Sheng ; Wang, Wei ; Xiao, Jun ; Tian, Dai-Shi ; Qin, Chuan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c564t-fd84918ccbb2db396f3394d2a044814e71eff796e16eeeabd5548371a3be21e53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Alcohol</topic><topic>Alzheimer's disease</topic><topic>Animals</topic><topic>Antibodies</topic><topic>Aquaporin 4</topic><topic>Brain</topic><topic>Care and treatment</topic><topic>Central Nervous System</topic><topic>Complement activation</topic><topic>Cytotoxicity</topic><topic>Demyelinating diseases</topic><topic>Demyelination</topic><topic>Diagnosis</topic><topic>Dosage and administration</topic><topic>Immunoglobulin G</topic><topic>Membrane Glycoproteins - genetics</topic><topic>Membrane Glycoproteins - metabolism</topic><topic>Mice</topic><topic>Microglia</topic><topic>Microglia - metabolism</topic><topic>Microscopy</topic><topic>Morphology</topic><topic>Myelin</topic><topic>Myelin Sheath - metabolism</topic><topic>Myeloid cells</topic><topic>Neurological complications</topic><topic>Neuromyelitis</topic><topic>Neuromyelitis optica</topic><topic>Neuromyelitis Optica - metabolism</topic><topic>Neuromyelitis optica spectrum disorder</topic><topic>Neuroprotection</topic><topic>Oligodendrocytes</topic><topic>Phagocytosis</topic><topic>Phagocytosis - genetics</topic><topic>Proteins</topic><topic>Receptors, Immunologic - genetics</topic><topic>Receptors, Immunologic - metabolism</topic><topic>TREM2</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>You, Yun-Fan</creatorcontrib><creatorcontrib>Chen, Man</creatorcontrib><creatorcontrib>Tang, Yue</creatorcontrib><creatorcontrib>Yu, Wen-Xiang</creatorcontrib><creatorcontrib>Pang, Xiao-Wei</creatorcontrib><creatorcontrib>Chu, Yun-Hui</creatorcontrib><creatorcontrib>Zhang, Hang</creatorcontrib><creatorcontrib>Shang, Ke</creatorcontrib><creatorcontrib>Deng, Gang</creatorcontrib><creatorcontrib>Zhou, Luo-Qi</creatorcontrib><creatorcontrib>Yang, Sheng</creatorcontrib><creatorcontrib>Wang, Wei</creatorcontrib><creatorcontrib>Xiao, Jun</creatorcontrib><creatorcontrib>Tian, Dai-Shi</creatorcontrib><creatorcontrib>Qin, Chuan</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Journal of neuroinflammation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>You, Yun-Fan</au><au>Chen, Man</au><au>Tang, Yue</au><au>Yu, Wen-Xiang</au><au>Pang, Xiao-Wei</au><au>Chu, Yun-Hui</au><au>Zhang, Hang</au><au>Shang, Ke</au><au>Deng, Gang</au><au>Zhou, Luo-Qi</au><au>Yang, Sheng</au><au>Wang, Wei</au><au>Xiao, Jun</au><au>Tian, Dai-Shi</au><au>Qin, Chuan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>TREM2 deficiency inhibits microglial activation and aggravates demyelinating injury in neuromyelitis optica spectrum disorder</atitle><jtitle>Journal of neuroinflammation</jtitle><addtitle>J Neuroinflammation</addtitle><date>2023-04-03</date><risdate>2023</risdate><volume>20</volume><issue>1</issue><spage>89</spage><epage>89</epage><pages>89-89</pages><artnum>89</artnum><issn>1742-2094</issn><eissn>1742-2094</eissn><abstract>Neuromyelitis optica spectrum disorder (NMOSD) is an inflammatory demyelinating disorder of the central nervous system (CNS) triggered by autoimmune mechanisms. Microglia are activated and play a pivotal role in response to tissue injury. Triggering receptor expressed on myeloid cells 2 (TREM2) is expressed by microglia and promotes microglial activation, survival and phagocytosis. Here, we identify a critical role for TREM2 in microglial activation and function during AQP4-IgG and complement-induced demyelination. TREM2-deficient mice had more severe tissue damage and neurological impairment, as well as fewer oligodendrocytes with suppressed proliferation and maturation. The number of microglia clustering in NMOSD lesions and their proliferation were reduced in TREM2-deficient mice. Moreover, morphology analysis and expression of classic markers showed compromised activation of microglia in TREM2-deficient mice, which was accompanied by suppressed phagocytosis and degradation of myelin debris by microglia. These results overall indicate that TREM2 is a key regulator of microglial activation and exert neuroprotective effects in NMOSD demyelination.</abstract><cop>England</cop><pub>BioMed Central Ltd</pub><pmid>37013543</pmid><doi>10.1186/s12974-023-02772-3</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1742-2094 |
ispartof | Journal of neuroinflammation, 2023-04, Vol.20 (1), p.89-89, Article 89 |
issn | 1742-2094 1742-2094 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_640bed233aa54a44b7d224c0af3bb0b4 |
source | PubMed Central Free; Publicly Available Content Database |
subjects | Alcohol Alzheimer's disease Animals Antibodies Aquaporin 4 Brain Care and treatment Central Nervous System Complement activation Cytotoxicity Demyelinating diseases Demyelination Diagnosis Dosage and administration Immunoglobulin G Membrane Glycoproteins - genetics Membrane Glycoproteins - metabolism Mice Microglia Microglia - metabolism Microscopy Morphology Myelin Myelin Sheath - metabolism Myeloid cells Neurological complications Neuromyelitis Neuromyelitis optica Neuromyelitis Optica - metabolism Neuromyelitis optica spectrum disorder Neuroprotection Oligodendrocytes Phagocytosis Phagocytosis - genetics Proteins Receptors, Immunologic - genetics Receptors, Immunologic - metabolism TREM2 |
title | TREM2 deficiency inhibits microglial activation and aggravates demyelinating injury in neuromyelitis optica spectrum disorder |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T20%3A06%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=TREM2%20deficiency%20inhibits%20microglial%20activation%20and%20aggravates%20demyelinating%20injury%20in%20neuromyelitis%20optica%20spectrum%20disorder&rft.jtitle=Journal%20of%20neuroinflammation&rft.au=You,%20Yun-Fan&rft.date=2023-04-03&rft.volume=20&rft.issue=1&rft.spage=89&rft.epage=89&rft.pages=89-89&rft.artnum=89&rft.issn=1742-2094&rft.eissn=1742-2094&rft_id=info:doi/10.1186/s12974-023-02772-3&rft_dat=%3Cgale_doaj_%3EA744216933%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c564t-fd84918ccbb2db396f3394d2a044814e71eff796e16eeeabd5548371a3be21e53%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2803047364&rft_id=info:pmid/37013543&rft_galeid=A744216933&rfr_iscdi=true |